Hikma Pharmaceuticals PLC's (LON:HIK) P/E Is On The Mark
Nov 11
Have your own idea? Try our Stock Screener
U.K. (FTSE) Pharma Industry Analysis
UpdatedNov 21, 2024
DataAggregated Company Financials
Companies18
- 7D-2.3%
- 3M-21.7%
- 1Y-2.8%
- YTDn/a
Over the last 7 days, the Pharma industry has dropped 2.3%, driven by a pullback from AstraZeneca of 2.2%. As for the longer term, the industry's performance has been flat for the past year. Earnings are forecast to grow by 19% annually.
Industry Valuation and Performance
Has the U.K. Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 21 Nov 2024 | UK£215.0b | UK£75.1b | UK£7.7b | 30.1x | 27.8x | 2.9x |
| Sat, 19 Oct 2024 | UK£252.7b | UK£72.3b | UK£9.0b | 30.9x | 27.9x | 3.5x |
| Mon, 16 Sep 2024 | UK£259.0b | UK£72.1b | UK£9.0b | 37.7x | 28.7x | 3.6x |
| Wed, 14 Aug 2024 | UK£273.3b | UK£72.9b | UK£9.1b | 40x | 30.1x | 3.8x |
| Fri, 12 Jul 2024 | UK£256.4b | UK£70.9b | UK£9.5b | 30.3x | 27.1x | 3.6x |
| Sun, 09 Jun 2024 | UK£268.8b | UK£71.5b | UK£9.6b | 30.5x | 28.1x | 3.8x |
| Tue, 07 May 2024 | UK£265.3b | UK£71.9b | UK£9.6b | 33x | 27.6x | 3.7x |
| Thu, 04 Apr 2024 | UK£240.9b | UK£70.7b | UK£9.7b | 31.9x | 24.8x | 3.4x |
| Sat, 02 Mar 2024 | UK£233.2b | UK£70.7b | UK£9.7b | 30.8x | 23.9x | 3.3x |
| Mon, 29 Jan 2024 | UK£237.3b | UK£68.9b | UK£10.7b | 35.9x | 22.2x | 3.4x |
| Wed, 27 Dec 2023 | UK£232.3b | UK£68.9b | UK£10.7b | 34.8x | 21.8x | 3.4x |
| Fri, 24 Nov 2023 | UK£226.9b | UK£69.4b | UK£10.7b | 52.9x | 21.1x | 3.3x |
| Sun, 22 Oct 2023 | UK£234.8b | UK£70.7b | UK£10.4b | 53.5x | 22.7x | 3.3x |
| Tue, 19 Sep 2023 | UK£241.9b | UK£70.0b | UK£10.3b | 53.5x | 23.5x | 3.5x |
| Thu, 17 Aug 2023 | UK£238.5b | UK£68.9b | UK£10.1b | 53.5x | 23.5x | 3.5x |
| Sat, 15 Jul 2023 | UK£226.8b | UK£66.6b | UK£7.8b | 54.3x | 29.2x | 3.4x |
| Mon, 12 Jun 2023 | UK£250.7b | UK£68.2b | UK£7.9b | 55.1x | 31.6x | 3.7x |
| Wed, 10 May 2023 | UK£256.8b | UK£68.1b | UK£7.9b | 57.3x | 32.4x | 3.8x |
| Fri, 07 Apr 2023 | UK£254.7b | UK£69.2b | UK£6.9b | 50.5x | 37.1x | 3.7x |
| Sun, 05 Mar 2023 | UK£238.0b | UK£70.5b | UK£7.0b | 50.3x | 34.2x | 3.4x |
| Tue, 31 Jan 2023 | UK£236.7b | UK£79.1b | UK£6.3b | 38.5x | 37.6x | 3x |
| Thu, 29 Dec 2022 | UK£245.0b | UK£80.3b | UK£6.3b | 38x | 38.6x | 3.1x |
| Sat, 26 Nov 2022 | UK£237.5b | UK£80.1b | UK£6.3b | 33.2x | 37.5x | 3x |
| Mon, 24 Oct 2022 | UK£217.0b | UK£81.0b | UK£3.7b | 20.9x | 59.4x | 2.7x |
| Wed, 21 Sep 2022 | UK£220.2b | UK£80.3b | UK£3.7b | 14.8x | 59.8x | 2.7x |
| Fri, 19 Aug 2022 | UK£240.1b | UK£78.2b | UK£3.8b | 14.8x | 64x | 3.1x |
| Sun, 17 Jul 2022 | UK£272.4b | UK£75.6b | UK£4.6b | 16.1x | 59.6x | 3.6x |
| Tue, 14 Jun 2022 | UK£251.3b | UK£74.7b | UK£4.6b | 15.9x | 55.1x | 3.4x |
| Thu, 12 May 2022 | UK£255.9b | UK£74.2b | UK£4.6b | 16.2x | 56x | 3.4x |
| Sat, 09 Apr 2022 | UK£275.1b | UK£66.8b | UK£4.8b | 20.5x | 57.2x | 4.1x |
| Mon, 07 Mar 2022 | UK£225.2b | UK£66.4b | UK£4.7b | 25x | 47.5x | 3.4x |
| Wed, 02 Feb 2022 | UK£231.4b | UK£61.4b | UK£5.6b | 34.1x | 41.1x | 3.8x |
| Fri, 31 Dec 2021 | UK£235.1b | UK£61.4b | UK£5.6b | 32.5x | 41.7x | 3.8x |
| Sun, 28 Nov 2021 | UK£225.3b | UK£61.7b | UK£5.7b | 30.3x | 39.8x | 3.6x |
Price to Earnings Ratio
39.8x
Current Industry PE
- Investors are pessimistic on the British Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 27.8x which is lower than its 3-year average PE of 38.2x.
- The 3-year average PS ratio of 3.5x is higher than the industry's current PS ratio of 2.9x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 11% per year over the last three years.
- Revenues for these companies have grown 6.7% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Comparison
How does U.K. Pharma compare with similar industries?
| GB Market | 0.73% | |
| Healthcare | -2.38% | |
| Pharma | -2.29% | |
| Pharma | -2.29% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| HIK Hikma Pharmaceuticals | UK£18.72 | 4.3% +UK£173.0m | 6.8% | PE18.4x | |
| HCM HUTCHMED (China) | UK£2.81 | 6.0% +UK£136.7m | -6.3% | PS5x | |
| INDV Indivior | UK£8.37 | 5.9% +UK£59.8m | -38.0% | PS1.1x | |
| REDX Redx Pharma | UK£0.15 | 62.2% +UK£22.4m | -53.8% | PS13.9x | |
| DPH Dechra Pharmaceuticals | UK£38.66 | 0.2% +UK£6.8m | 32.4% | PS5.8x |
